4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.

Journal article

J Jacobson, B Sleebs, K Jarman, W Nguyen, T Mota, L Harty, G Khoury, N Tay, P Cameron, S Lewin, DFJ Purcell

Journal of Virus Eradication | Elsevier BV | Published : 2017